The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) represents global research-based pharmaceutical companies and associations. Its base of 2 million members research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations.
The Global Self-Care Federation (GSCF) represents associations and manufacturers in the self-care industry and aims to create a healthier world through responsible self-care. GSCF ensures evidence-based self-care products and solutions are recognised as key contributors to health for individuals and healthcare systems worldwide. GSCF is non-governmental organization and has official relations with the World Health Organization (WHO).
The World Health Organization (WHO) leads global efforts to expand Universal Health Coverage. They direct and coordinate the world’s health capacities and response to health emergencies. WHO also promotes healthier lives from pregnancy care through old age.
Pharmaceutical Research and Manufacturers of America (PhRMA) strives to conduct effective advocacy for public policies that encourage the discovery of important new medicines for patients by biopharmaceutical research companies. To accomplish this, PhRMA works with multiple stakeholders in Washington DC and across the world.
The World Trade Organization (WTO) is a global international organisation dealing with the rules of trade between nations. At its heart are the WTO agreements, negotiated and signed by the majority of the world’s trading nations and ratified in their parliaments. The goal is to help producers of goods and services, exporters, and importers conduct their business.
The Asia-Pacific Economic Cooperation (APEC) is a regional economic forum established in 1989 to leverage the growing interdependence of the Asia-Pacific. APEC has 21 members and aims to create greater prosperity for the people of the region by promoting balanced, inclusive, sustainable, innovative and secure growth and by accelerating regional economic integration.
APAC is an industry-driven initiative led by R&D-based pharmaceutical associations from Asian economies with the mission of expediting the launch of innovative medicines for the Asian population. APAC’s concept of “Access to Innovative Medicines (ATIM)” focuses on Drug Discovery Alliances (DA), Regulatory Approval Systems (RA), Good Manufacturing Practices (GMP), Intellectual Property (IP), R&D and others.
The Singapore Association of Pharmaceutical Industries (SAPI) aims to make innovative medicine accessible to patients in Singapore. SAPI achieves this through a sustainable and valued partnership with healthcare professionals and providers, government and patient group stakeholders, and a reputation of consistent ethical behaviour.